From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...

Researchers say early deep brain stimulation and emerging therapies could reshape expectations for patients diagnosed in the U.S.

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

The Parkinson's Foundation released Parkinson's Care and Innovation: A Patient-Centered Agenda for Change, the first national strategy to transform Parkinson's disease (PD) care. It represents the ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

For many, hearing the word “Parkinson’s” conjures an image of tremors. But Parkinson’s disease, brought about by loss of nerve and other brain cells, is actually an incredibly complex movement ...

The Michael J. Fox Foundation for Parkinson's Research, which Michael J. Fox founded in 2000, nine years after he was diagnosed with the neurodegenerative disease, turned 25 this year In the new issue ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements. Subscribe to our ...